Adma Biologics, Inc.
ADMA
Revenue
107.19M
▲25.32M▲30.92%
3 Months ChangeAssets
376.40M
▲25.52M▲7.27%
3 Months ChangeLiabilities
188.13M
▼-9.04M▼-4.58%
3 Months ChangeFree Cash Flow
-4.57M
▲12.10M▲72.61%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001140361-24-044808
2024-10-10
Form 8-K
ID: 0001140361-24-043250
2024-10-09
Form 8-K
ID: 0001140361-24-043222
2024-08-14
Form 8-K
ID: 0001140361-24-037184
2024-08-08
Form 10-Q
ID: 0001140361-24-036432
2024-08-08
Form 8-K
ID: 0001140361-24-036399
2024-07-26
Form 8-K
ID: 0001140361-24-034440
2024-06-28
Form 8-K
ID: 0001140361-24-031778
2024-06-04
Form 8-K
ID: 0001140361-24-028800
2024-05-17
Form 8-K
ID: 0001140361-24-026601